The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 138, No 12, 1555-1562.
© 2007 American Dental Association

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Epstein, J. B.
Right arrow Articles by Elad, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Epstein, J. B.
Right arrow Articles by Elad, S.
Related Collections
Right arrow Imaging

CLINICAL PRACTICE

JADA Continuing Education

A Survey of the Current Approaches to Diagnosis and Management of Oral Premalignant Lesions



Joel B. Epstein, DMD, MSD, FRCD(C), FDSRCSE, Meir Gorsky, DMD, Dena Fischer, DDS, MSD, MS, Anurag Gupta, BDS, MPH, Matthew Epstein, BSc and Sharon Elad, DMD, MSc

Background. Early diagnosis of oral premalignant lesions (OPLs) and oral squamous cell carcinoma facilitates treatment with less aggressive approaches and results in a better prognosis. The authors conducted a study to identify current practices in the diagnosis and management of these oral lesions by oral medicine professionals.

Methods. The authors sent a questionnaire to 176 diplomates of the American Board of Oral Medicine and asked them to complete the questionnaires and return them by mail.

Results. The initial clinical approach taken by most of the responders included visual examination, elimination of possible local causes and two-week follow-up. Adjuvant clinical tests included toluidine blue, oral brush biopsy and exfoliative cytology. If there was no clinical improvement after two weeks, most responders recommended that a biopsy be performed. Induration, red component, nonhomogeneous surface and ulceration were characteristics of lesions that increased the responders’ decisions to perform a biopsy. Lesion symptoms and location also contributed to their decisions to perform a biopsy. Follow-up more frequently than twice a year was recommended for red lesions, lesions with histologically confirmed dysplasia or both. Most clinicians recommend a biopsy during follow-up of an OPL whenever the lesion changes in appearance.

Conclusions. The findings of this survey may provide background for initial guidelines to be used by oral practitioners to diagnose and manage OPL. Clinicians’ awareness of the complexity of OPL diagnosis and management is important, and referral to an experienced provider is recommended.

Key Words: Oral premalignant lesions; leukoplakia; erythroplakia; diagnosis; management

Abbreviations: ABOM: American Board of Oral Medicine • FDA: U.S. Food and Drug Administration • OPL: Oral premalignant lesion • OSCC: Oral squamous cell carcinoma • WHO: World Health Organization







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright©1995-2007 American Dental Association (ADA).
Reproduction or republication strictly prohibited without prior written permission of ADA.